Global Roundtable Corporation (GRCU)

0.0001 -0.0001 (-50.00%) At close: 12:33PM EDT

Global Roundtable Corporation

7535 East Avenue
Denver, CO 80231
United States

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full Time Employees: 20

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Rich Thomas	Chief Executive Officer	N/A	N/A	N/A
Mr. Michael Lajtay	President, Chief Operating Officer and Lead Product Developer	N/A	N/A	N/A
Mr. Benjamin Craik	Chief Technology Officer	N/A	N/A	N/A
Mr. David Moceri	Chief Marketing Officer	N/A	N/A	N/A
Mr. Joseph Tragesser	Consultant & Advisor	N/A	N/A	N/A

Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Global Roundtable Corporation operates in the health and wellness business. It also provides products and ancillary services in the mental wellness segment and optical-vision medical care. The company was formerly known as Green Cures & Botanical Distribution Inc. and changed its name to Global Roundtable Corporation in May 2023. Global Roundtable Corporation was incorporated in 1986 and is based in Denver, Colorado.

Corporate Governance

Global Roundtable Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.